AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30684522
Drug: Hydrocortisone (unspecific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (unspecific MR/GR agonist)
Trial: 30684522
Drug: Fludrocortisone (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone (specific MR agonist)
Trial: 28760368
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (ACG)
Trial: 28760368
Drug: No adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjuvant chemotherapy (NACG)
Trial: 19919718
Drug: Activities of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activities of daily living (bathing, dressing, eating, walking) without counselling from a physical therapist
Trial: 11139961
Drug: sotalol (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotalol (160 mg bid)
Trial: 9052343
Drug: Propafenone 2
RxNorm normalized name: propafenone 225 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 2 mg/kg over 30 minutes, followed by oral propafenone 150 mg 3 times daily
Trial: 9052343
Drug: Propafenone 150
RxNorm normalized name: propafenone 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 150 mg 3 times daily
Trial: 2427858
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg celiprolol for 3 weeks, then increased to 300 mg or added diuretic for another 3 weeks
Trial: 2427858
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg celiprolol
Trial: 2427858
Drug: Diuretic added
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diuretic added to treatment
Trial: 2427858
Drug: Celiprolol administered
RxNorm normalized name: celiprolol
DrugBank: Celiprolol (DB04846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol administered for up to 6 weeks
Trial: 31606288
Drug: Mid-treatment MRI
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mid-treatment MRI showing complete response (mCR)
Trial: 31606288
Drug: Mid-treatment MRI
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mid-treatment MRI showing partial response (mPR)
Trial: 20392890
Drug: Red tomato
RxNorm normalized name: Tomato
DrugBank: Tomato (DB10573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red tomato paste (200 g/d providing 16 mg lycopene)
Trial: 20392890
Drug: Purified lycopene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified lycopene (16 mg/d)
Trial: 20392890
Drug: Yellow tomato
RxNorm normalized name: Tomato
DrugBank: Tomato (DB10573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yellow tomato paste (200 g/d providing 0 mg lycopene)
Trial: 18923312
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg intrathecal morphine (M-group)
Trial: 12808527
Drug: Group-based multidisciplinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based multidisciplinary cognitive behavioral therapy
Trial: 12808527
Drug: Individual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual therapy cognitive behavioral therapy
Trial: 11304027
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) infusion (0.5 microg/kg per min for 20 min)
Trial: 11304027
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) infusion
Trial: 1365868
Drug: Vitamin B-6
RxNorm normalized name: Vitamin B-6 100mg Tablet
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B-6 supplementation (20 mg pyridoxine HCL daily for 3 months)
Trial: 6532126
Drug: Indomethacin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (4 X 25 mg, orally)
Trial: 6532126
Drug: Sodium salicylate
RxNorm normalized name: Sodium Salicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium salicylate (4 X 250 mg, orally)
Trial: 6532126
Drug: Indomethacin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (25 mg) plus sodium salicylate (250 mg) (Pelsonin, 4 X 1 capsules)
Trial: 30439945
Drug: WHO dose
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: WHO dose pole for praziquantel (PZQ) dosing
Trial: 30439945
Drug: Modified dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified dose pole for praziquantel (PZQ) dosing
Trial: 25643511
Drug: 2-week anti-HP
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 2-week anti-HP therapy plus 90-day oral iron
Trial: 25643511
Drug: 2-week anti-HP
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 2-week anti-HP therapy alone
Trial: 25643511
Drug: 90-day oral
RxNorm normalized name: estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 90-day oral iron alone
Trial: 8607674
Drug: Heparin-coated circuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated circuits (Duraflo II)
Trial: 1833245
Drug: Danazol 800
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol 800 mg/d
Trial: 7139067
Drug: S-carboxymethylcysteine in
RxNorm normalized name: S-carboxymethylcysteine
DrugBank: Carbocisteine (DB04339)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-carboxymethylcysteine in hard gelatin capsule
Trial: 7139067
Drug: S-carboxymethylcysteine syrup
RxNorm normalized name: S-carboxymethylcysteine
DrugBank: Carbocisteine (DB04339)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-carboxymethylcysteine syrup
Trial: 30088162
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen plus thoracic epidural analgesia (TEA)
Trial: 19129989
Drug: Acetaminophen 15
RxNorm normalized name: acetaminophen 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 15 mg/kg/dose (n=112)
Trial: 19129989
Drug: Ketoprofen 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 0.5 mg/kg/dose (n=105)
Trial: 19129989
Drug: Ibuprofen 10
RxNorm normalized name: ibuprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 10 mg/kg/dose (n=84)
Trial: 15385923
Drug: All-trans retinoic
RxNorm normalized name: all trans Retinoic acid
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All-trans retinoic acid (ATRA) given as adjunct to chemotherapy (ATRA-arm, n=122)
Trial: 15385923
Drug: Intensive consolidation
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive consolidation therapy (n=31)
Trial: 11125238
Drug: Tacrine 40
RxNorm normalized name: tacrine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrine 40 mg
Trial: 11806464
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 or 8 mg once daily)
Trial: 11806464
Drug: Nitrendipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (20 or 40 mg once daily)
Trial: 7822984
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (200 mg of oral vitamin E for 4-8 weeks)
Trial: 38214
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg labetalol
Trial: 29248384
Drug: Telmisartan/Amlodipine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan/Amlodipine + Hydrochlorothiazide (TAH) 40/5 mg + 12.5 mg
Trial: 29248384
Drug: Telmisartan/Amlodipine (TA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan/Amlodipine (TA) 40/5 mg
Trial: 18769354
Drug: EVG/r alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVG/r alone (200/100 mg once daily)
Trial: 18769354
Drug: EVG added
RxNorm normalized name: EVG
DrugBank: Elvitegravir (DB09101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: EVG added to TPV/r (500/200 mg twice daily)
Trial: 18769354
Drug: EVG added
RxNorm normalized name: EVG
DrugBank: Elvitegravir (DB09101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: EVG added to DRV/r (600/100 mg twice daily)
Trial: 18769354
Drug: EVG/r (200/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVG/r (200/100 mg once daily)
Trial: 18769354
Drug: EVG/r (125/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVG/r (125/100 mg once daily)
Trial: 12020337
Drug: 30 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g/d of alcohol for 8 weeks
Trial: 12020337
Drug: 15 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g/d of alcohol for 8 weeks
Trial: 12020337
Drug: 0 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g/d of alcohol for 8 weeks
Trial: 10519499
Drug: Prerandomized consent
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prerandomized consent to experimental treatment
Trial: 10519499
Drug: Prerandomized consent
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prerandomized consent to standard treatment
Trial: 8537265
Drug: Meropenem 1
RxNorm normalized name: meropenem 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 1 g tds iv
Trial: 8537265
Drug: Ceftazidime 2
RxNorm normalized name: ceftazidime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 2 g tds iv
Trial: 27916242
Drug: Pregabalin and
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin and methylcobalamin combination (PG‐B12)
Trial: 23890528
Drug: Type I
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type I trimming technique (1-cm incision, glandular and subcutaneous tissue removal using scissors)
Trial: 23013746
Drug: Enzyme replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme replacement therapy (ERT) with 20 mg/kg alglucosidase alfa biweekly
Trial: 20128370
Drug: Drug Eluting
RxNorm normalized name: Drug eluting stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Eluting Stent (DES)
Trial: 17541390
Drug: Aliskiren 150
RxNorm normalized name: aliskiren 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 150 mg (dose titrated to 300 mg if needed)
Trial: 17541390
Drug: Lisinopril 20
RxNorm normalized name: lisinopril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 20 mg (dose titrated to 40 mg if needed)
Trial: 9724486
Drug: Intensive diabetes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive diabetes therapy aimed at near normoglycemia
Trial: 7979840
Drug: Acarbose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (50 to 300 mg three times per day)
Trial: 825076
Drug: Thyrotropin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin-releasing hormone (TRH) stimulation
Trial: 825076
Drug: Three intravenous
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three intravenous doses of 600 mug of TRH over 15 days
Trial: 27791532
Drug: Rational emotive
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rational emotive behaviour therapy (REBT)
Trial: 25726502
Drug: Tenecteplase 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenecteplase 0.25 mg/kg (maximum 25 mg)
Trial: 19807152
Drug: Xanthone-rich mangosteen
RxNorm normalized name: xanthine
DrugBank: Xanthine (DB02134)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xanthone-rich mangosteen liquid (59 mL)
Trial: 16731547
Drug: Norethisterone enanthate
RxNorm normalized name: norethindrone enanthate
DrugBank: Norethindrone enanthate (DB14678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norethisterone enanthate and testosterone undecanoate injections
Trial: 10910852
Drug: IV verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV verapamil 2.5 mg and morphine 5 mg added to lidocaine solution (Group 3)
Trial: 10910852
Drug: IV morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV morphine 5 mg and verapamil 2.5 mg added to lidocaine solution (Group 4)
Trial: 10910852
Drug: verapamil 2.5
RxNorm normalized name: verapamil 2.5 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 2.5 mg and morphine 5 mg added to lidocaine solution (Group 5)
Trial: 9071903
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (160 mg daily)
Trial: 25882376
Drug: Thrombectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombectomy with stent retriever plus intravenous t-PA
Trial: 25882376
Drug: Intravenous t-PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous t-PA alone (control group)
Trial: 24195220
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (pinaverium bromide tablet)
Trial: 15968385
Drug: LPS inhalation
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPS inhalation
Trial: 9203722
Drug: Monovalent type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent type 1 oral poliovirus vaccine (OPV) at 6 months and trivalent OPV at 7 and 9 months (Group 1)
Trial: 9203722
Drug: OPV at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPV at birth and 3 doses of OPV and inactivated poliovirus vaccine (IPV) (Group 2)
Trial: 9203722
Drug: Placebo at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo at birth and 3 doses of IPV (Group 3)
Trial: 9203722
Drug: Monovalent type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent type 1 OPV following 3 IPV doses (Group 2)
Trial: 7703709
Drug: Orientation Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orientation Group intervention to reduce waiting time for treatment
Trial: 3237852
Drug: Balloon inflated
RxNorm normalized name: LOBELIA INFLATA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balloon inflated with 400 ml or more of water
Trial: 31206595
Drug: Patch test
RxNorm normalized name: Patch test product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch test reactivity to fragrance mix I
Trial: 27052688
Drug: IV metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV metoprolol (15 mg bolus)
Trial: 20100808
Drug: EQ plus
RxNorm normalized name: Anthelcide EQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EQ plus 8 weeks of nicotine transdermal patch (EQ+)
Trial: 15741547
Drug: Glucantime (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucantime (20 mg of antimony [Sb]/kg/day intravenously for 20 days)
Trial: 15741547
Drug: Pentamidine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentamidine (2 mg/kg every other day for seven injections)
Trial: 9990361
Drug: Ointment base
RxNorm normalized name: Ointment base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment base (placebo)
Trial: 7996960
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 200 ppb sulphur dioxide and 400 ppb nitrogen dioxide
Trial: 29859917
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose lithium (150-600 mg) targeting a blood level of 0.2-0.6 mmol/L
Trial: 27792869
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g transdermal testosterone gel (TT) daily for 12 months
Trial: 27792869
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg anastrozole (AI) daily for 12 months
Trial: 11809341
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily for 12 months
Trial: 22457097
Drug: Extracorporeal cardiac
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extracorporeal cardiac shock wave therapy (CSWT)
Trial: 19583713
Drug: Itraconazole with
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole with lactobacilli (200 mg bid for acute infection followed by monthly single-day treatment)
Trial: 19583713
Drug: Itraconazole without
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole without lactobacilli (200 mg bid for acute infection followed by monthly single-day treatment)
Trial: 19583713
Drug: Classic homeopathy
RxNorm normalized name: Urtica urens homeopathic preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classic homeopathy (CH) treatment for 12 months
Trial: 9779696
Drug: CR oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CR oxycodone every 12 hours
Trial: 9779696
Drug: IR oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IR oxycodone four times daily
Trial: 3092656
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg three times daily and 400 mg at night
Trial: 2735329
Drug: Sucralfate 1
RxNorm normalized name: sucralfate 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate 1 g four times daily followed by 1 g twice daily after healing
Trial: 25528496
Drug: Pilaralisib 600mg
RxNorm normalized name: Pilaralisib
DrugBank: Pilaralisib (DB11772)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilaralisib 600mg capsules or 400mg tablets once daily
Trial: 8576779
Drug: Risk factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk factor modification (cholesterol reduction therapy)
Trial: 8576779
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists and diuretics
Trial: 28806348
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 100 mg/day
Trial: 28806348
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 300 mg/day
Trial: 19080128
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy with cisplatin and fluorouracil (PF) regimen
Trial: 19080128
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (locoregional treatment alone)
Trial: 16966497
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg zolmitriptan nasal spray (ZNS5)
Trial: 16966497
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg zolmitriptan nasal spray (ZNS10)
Trial: 16966497
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg zolmitriptan nasal spray (ZNS5) (episodic cluster headache)
Trial: 16966497
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg zolmitriptan nasal spray (ZNS10) (episodic cluster headache)
Trial: 16966497
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg zolmitriptan nasal spray (ZNS5) (chronic cluster headache)
Trial: 16966497
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg zolmitriptan nasal spray (ZNS10) (chronic cluster headache)
Trial: 3159401
Drug: Neuramide therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuramide therapy
Trial: 21593041
Drug: Mipomersen (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen (dose not specified, up to 400 mg/week)
Trial: 16945749
Drug: Aggressive medical
RxNorm normalized name: ZO SKIN HEALTH Aggressive Anti-Aging Program KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive medical therapy
Trial: 16945749
Drug: Percutaneous coronary
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous coronary intervention plus aggressive medical therapy
Trial: 16945749
Drug: Sequential gSPECT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential gSPECT monitoring (n = 300)
Trial: 9756286
Drug: Interventive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interventive treatment (surgical ligation or angiographic embolization of the spermatic vein)
Trial: 9756286
Drug: Counselling as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Counselling as the sole treatment
Trial: 8165195
Drug: Superchar (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Superchar (30 g)
Trial: 8165195
Drug: Actidose (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actidose (30 g)
Trial: 8165195
Drug: Charcoaid (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Charcoaid (30 g)
Trial: 3349861
Drug: Cefoperazone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone (2 g i.v. every 8 h)